Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$22.33

-0.31 (-1.37%)

As of Jun 21, 10:14 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target +1.7% upside

Low Target $15.64

Average Target $22.71

High Target $35.67

Current Price $22.33

Current
$22.33

Target
$22.71

$15.64 $22.71 avg $35.67

Scenario Analysis

Bear Case

$15.64

-30.0%

Low target

Base Case

$22.71

+1.7%

Avg target

Bull Case

$35.67

+59.7%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$27.64

-19.2% from high

52-Week Low

$18.80

+18.8% from low

Target vs 52W High

$22.71

-17.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+18.3%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+22.2%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+27.7%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+42.3%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+170.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%